Your browser doesn't support javascript.
loading
Role of Post-Translational Modifications in Colorectal Cancer Metastasis.
Peng, Na; Liu, Jingwei; Hai, Shuangshuang; Liu, Yihong; Zhao, Haibo; Liu, Weixin.
Afiliação
  • Peng N; Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
  • Liu J; Department of Anus and Intestine Surgery, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
  • Hai S; Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
  • Liu Y; Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
  • Zhao H; Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
  • Liu W; Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.
Cancers (Basel) ; 16(3)2024 Feb 03.
Article em En | MEDLINE | ID: mdl-38339403
ABSTRACT
Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract. CRC metastasis is a multi-step process with various factors involved, including genetic and epigenetic regulations, which turn out to be a serious threat to CRC patients. Post-translational modifications (PTMs) of proteins involve the addition of chemical groups, sugars, or proteins to specific residues, which fine-tunes a protein's stability, localization, or interactions to orchestrate complicated biological processes. An increasing number of recent studies suggest that dysregulation of PTMs, such as phosphorylation, ubiquitination, and glycosylation, play pivotal roles in the CRC metastasis cascade. Here, we summarized recent advances in the role of post-translational modifications in diverse aspects of CRC metastasis and its detailed molecular mechanisms. Moreover, advances in drugs targeting PTMs and their cooperation with other anti-cancer drugs, which might provide novel targets for CRC treatment and improve therapeutic efficacy, were also discussed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article